Orthogonal activation of the reengineered A(3) adenosine receptor (neoceptor) using tailored nucleoside agonists

An alternative approach to overcome the inherent lack of specificity of conventional agonist therapy can be the reengineering of the GPCRs and their agonists. A reengineered receptor (neoceptor) could be selectively activated by a modified agonist, but not by the endogenous agonist. Assisted by rhod...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gao, Zhan-Guo, Duong, Heng T., Sonin, Tatiana, Kim, Soo-Kyung, Van Rompaey, Philippe, Van Calenbergh, Serge, Mamedova, Liaman, Kim, Hea Ok, Kim, Myong Jung, Kim, Ae Yil, Liang, Bruce T., Jeong, Lak Shin, Jacobson, Kenneth A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2006
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3471142/
https://ncbi.nlm.nih.gov/pubmed/16640329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm050968b
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller